Please use this identifier to cite or link to this item:
|Title:||Undertreatment of people with major depressive disorder in 21 countries||Authors:||Thornicroft, Graham
de Almeida, Jose Miguel Caldas
de Girolamo, Giovanni
Haro, Josep Maria
de Galvis, Yolanda Torres
Kessler, Ronald C
|Affiliations:||Faculty of Medicine||Issue Date:||2017||Part of:||British Journal of Psychiatry||Volume:||210||Issue:||2||Start page:||119||End page:||124||Abstract:||
Major depressive disorder (MDD) is a leading cause of disability worldwide.
To examine the: (a) 12-month prevalence of DSM-IV MDD; (b) proportion aware that they have a problem needing treatment and who want care; (c) proportion of the latter receiving treatment; and (d) proportion of such treatment meeting minimal standards.
Representative community household surveys from 21 countries as part of the World Health Organization World Mental Health Surveys.
Of 51 547 respondents, 4.6% met 12-month criteria for DSM-IV MDD and of these 56.7% reported needing treatment. Among those who recognised their need for treatment, most (71.1%) made at least one visit to a service provider. Among those who received treatment, only 41.0% received treatment that met minimal standards. This resulted in only 16.5% of all individuals with 12-month MDD receiving minimally adequate treatment.
Only a minority of participants with MDD received minimally adequate treatment: 1 in 5 people in high-income and 1 in 27 in low-/lower-middle-income countries. Scaling up care for MDD requires fundamental transformations in community education and outreach, supply of treatment and quality of services.
|URI:||https://scholarhub.balamand.edu.lb/handle/uob/5885||ISSN:||00071250||DOI:||10.1192/bjp.bp.116.188078||Open URL:||Link to full text||Type:||Journal Article|
|Appears in Collections:||Faculty of Medicine|
Show full item record
checked on Sep 24, 2022
checked on Sep 23, 2022
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.